Cutaneous Infections in the Office Setting

  • Nelson M. Gantz


The practicing clinician frequently encounters skin and soft tissue infections, which vary in severity from localized infections such as folliculitis to invasive and life-threatening illnesses such as necrotizing fasciitis. Factors that determine the extent of an infection include the infecting organism, predisposing conditions, and immunologic status of the host. A cutaneous rash may indicate a systemic disease such as toxic shock syndrome or reflect a localized process such as cellulitis. Systemic manifestations such as chills and fever may or may not be present in patients with skin and subcutaneous infections. The clinician must determine if hospitalization is indicated as well as which diagnostic studies and therapy should be initiated. Infections resulting from animal bites are discussed in Chapter 15. This chapter focuses on the common skin infections seen in the office practice.


Herpes Zoster Lyme Disease Necrotizing Fasciitis Postherpetic Neuralgia Toxic Shock Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Grieco M, Sheldon C: Erysipelothrix rhusiopathiae. Ann NY Acad Sci 1970; 174: 523–532.PubMedCrossRefGoogle Scholar
  2. 2.
    Wickbolt LG, Sanders CV: Vibrio vulnificus infection. A case report and update since 1970. J Acad Dermatol 1983; 9: 243–251.CrossRefGoogle Scholar
  3. 3.
    Grange JM: Mycobacteria and the skin. Int J Dermatol 1982; 21: 497–503.PubMedCrossRefGoogle Scholar
  4. 4.
    Wallace RJ: Nontuberculous mycobacteria and water: A love affair with increasing clinical importance. Infect Dis Clin North Am 1987; 1: 677–686.PubMedGoogle Scholar
  5. 5.
    Hanson PG, Standridge J, Jarrett F, et al: Freshwater wound infection due to Aeromonas hydrophilia. JAMA 1977; 238: 1053–1054.Google Scholar
  6. 6.
    Hirsch ML, Kass EH: An annotated bibliography of toxic shock syndrome. Rev Infect Dis 1986; 8: 51.Google Scholar
  7. 7.
    Feder HM Jr, Grant-Kels JM, Tilton RC: Pseudomonas whirlpool dermatitis: Report of an outbreak in two families. Clin Pediatr 1983; 22: 638–642.CrossRefGoogle Scholar
  8. 8.
    David BJ. Whirpool operation and the prevention of infection. Infect Control 1985; 6: 394–397.Google Scholar
  9. 9.
    Wheat LJ, Kohler RB, White AL, et al: Effect of rifampin on nasal carriers of coagulase-positive staphylococci. J Infect Dis 1981; 144: 177.PubMedCrossRefGoogle Scholar
  10. 10.
    McAnally TP, Lewis MR, Brown DR: Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus. Antimicrob Agents Chemother 1984; 25: 422–426.PubMedCrossRefGoogle Scholar
  11. 11.
    Shepp DH, Dandliker PS, Meyers JD: Treatment of varicella-zoster virus infection in severely immunocompromised patients: A randomized comparison of acyclovir and vidarabine. N Engl J Med 1986; 314: 208–212.PubMedCrossRefGoogle Scholar
  12. 12.
    Esmann V, Geil JP, Kroon S, et al: Prednisolone does not prevent post-herpetic neuralgia. Lancer 1987; 2: 126–129.CrossRefGoogle Scholar
  13. 13.
    Bean B, Braun C, Balfour HH Jr: Acyclovir therapy for acute herpes zoster. Lancet 1982; 2: 118121.Google Scholar
  14. 14.
    Shrestha M, Grodzicki RL, Steere AC: Diagnosing early Lyme disease. Am J Med 1985; 78: 235–240.PubMedCrossRefGoogle Scholar
  15. 15.
    Steere AC, Green J, Shoen RT, et al: Successful parenteral penicillin therapy of established Lyme arthritis. N Engl J Med 1985; 312: 869–874.PubMedCrossRefGoogle Scholar
  16. 16.
    Steere AC, Hutchinson GJ, Rahn DW, et al: Treatment of the early manifestations of Lyme disease. Ann Intern Med 1983; 99: 22–26.PubMedCrossRefGoogle Scholar
  17. 17.
    Weinstein L: Erythema nodosum. Disease-a-Month 1969; 1–30.Google Scholar
  18. 18.
    Weinstein AJ: Erythema nodosum. Infect Dis Pract 1981; 5: 2–4.Google Scholar
  19. 19.
    Soderstrom RM, Krull EA: Erythema nodosum: A review. Cutis 1978; 21: 806–810.PubMedGoogle Scholar
  20. 20.
    Winkelmann RK: New observations in the histopathology of erythema nodosum. J Invest Dermatol 1975; 65: 441–446.PubMedCrossRefGoogle Scholar
  21. 21.
    White JW Jr: Erythema nodosum. Dermatol Clin 1985; 3: 119–127.PubMedGoogle Scholar
  22. 22.
    Bullock WE: The clinical significance of erythema nodosum. Hosp Pract 1986; 21:102E–102H, 102K–102L, 102Q–102R.Google Scholar

Additional Reading

  1. Strams SE, Ostrove JM, Inschsupé , et al: Varicella-zoster virus. Biology, natural history, treatment and prevention. Ann Intern Med 1988; 108:221-237.Google Scholar
  2. Watson PN, Evans RJ: Postherpetic neuralia: A review. Arch Neurol 1986; 43:836-840.Google Scholar
  3. Ginberg MB: Cellulitis: Analysis of 101 cases and review of the literature. South Med J 1981; 74:530-533.Google Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Nelson M. Gantz

There are no affiliations available

Personalised recommendations